The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account


David Fiorentino, MD, PhD
Dermatologist, Psoriasis specialist, Autoimmune disease specialist
Practice Areas
Professional Education
- Board Certification: Dermatology, American Board of Dermatology (2002)
- B.S., Stanford University, Biological Sciences (1988)
- M.D., Stanford University (1998)
- Ph.D., Stanford University, Cancer Biology (1998)
- Medical Education: Stanford University School of Medicine (1998) CA
- Residency: Stanford University School of Medicine Registrar (2002) CA
- Internship: University of Colorado School of Medicine (1999) CO
Honors & Awards
- Clinical Immunology Faculty Scholarship Award, Center for Clinical Immunology at Stanford (2003-2006)
- Medical Dermatology Development Award, Dermatology Foundation (2004-2007)
Administrative Appointments
- Associate Director, Residency Program (2013 - Present)
- Founding member, North American Rheumatologic Dermatology Society (NARDS) (2006 - Present)
Publications
-
Cutaneous vasculitis
Fiorentino, D. F. (2003). Cutaneous vasculitis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 48(3), 311–340. -
Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions
Fiorentino, D. F., Nguyen, J. C., Egbert, B. M., & Swetter, S. M. (2004). Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 50(3), 476–478. -
RAPAMYCIN SELECTIVELY INHIBITS INTERLEUKIN-2 ACTIVATION OF P70 S6 KINASE
Kuo, C. J., Chung, J. K., Fiorentino, D. F., Flanagan, W. M., Blenis, J., & Crabtree, G. R. (1992). RAPAMYCIN SELECTIVELY INHIBITS INTERLEUKIN-2 ACTIVATION OF P70 S6 KINASE. NATURE, 358(6381), 70–73. -
Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil
Hantash, B., & Fiorentino, D. (2006). Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil. ARCHIVES OF DERMATOLOGY, 142(1), 109–110.
-
-
A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis
Chung, L., & Fiorentino, D. (2006). A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 54(5), 880–882.
-
PRODUCTION OF IL-10 BY CD4+ LYMPHOCYTES-T CORRELATES WITH DOWN-REGULATION OF TH1 CYTOKINE SYNTHESIS IN HELMINTH INFECTION
Sher, A., Fiorentino, D., Caspar, P., Pearce, E., & Mosmann, T. (1991). PRODUCTION OF IL-10 BY CD4+ LYMPHOCYTES-T CORRELATES WITH DOWN-REGULATION OF TH1 CYTOKINE SYNTHESIS IN HELMINTH INFECTION. JOURNAL OF IMMUNOLOGY, 147(8), 2713–2716.
-
DIVERSITY OF CYTOKINE SYNTHESIS AND FUNCTION OF MOUSE CD4+ T-CELLS
Mosmann, T. R., SCHUMACHER, J. H., STREET, N. F., Budd, R., OGARRA, A., Fong, T. A. T., … Fiorentino, D. F. (1991). DIVERSITY OF CYTOKINE SYNTHESIS AND FUNCTION OF MOUSE CD4+ T-CELLS. IMMUNOLOGICAL REVIEWS, 123, 209–229.
-
Epidemiology of FASD in a province in Italy: Prevalence and characteristics of children in a random sample of schools
May, P. A., Fiorentino, D., Gossage, J. P., Kalberg, W. O., Hoyme, H. E., Robinson, L. K., … Ceccanti, M. (2006). Epidemiology of FASD in a province in Italy: Prevalence and characteristics of children in a random sample of schools. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 30(9), 1562–1575.
-
Systemic and locatized scleroderma
Chung, L., Lin, J., Furst, D. E., & Fiorentino, D. (2006). Systemic and locatized scleroderma. CLINICS IN DERMATOLOGY, 24(5), 374–392.
-
Successful use of rituximab for cutaneous vasculitis
Chung, L., Funke, A. A., Chakravarty, E. F., Callen, J. P., & Fiorentino, D. F. (2006). Successful use of rituximab for cutaneous vasculitis. ARCHIVES OF DERMATOLOGY, 142(11), 1407–1410.
-
Update on cutaneous vasculitis
Grzeszkiewicz, T. M., & Fiorentino, D. F. (2006). Update on cutaneous vasculitis. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 25(4), 221–225.
-
A pilot trial of rituximab in the treatment of patients with dermatomyositis
Chung, L., Genovese, M. C., & Fiorentino, D. F. (2007). A pilot trial of rituximab in the treatment of patients with dermatomyositis. ARCHIVES OF DERMATOLOGY, 143(6), 763–767.
-
Nephrogenic systemic fibrosis - Relationship to gadolinium and response to photopheresis
Richmond, H., Zwerner, J., Kim, Y., & Fiorentino, D. (2007). Nephrogenic systemic fibrosis - Relationship to gadolinium and response to photopheresis. ARCHIVES OF DERMATOLOGY, 143(8), 1025–1030.
-
Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis
Hantash, B. M., Chiang, D., Kohler, S., & Fiorentino, D. (2008). Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 58(4), 661–664.
-
Mycophenolate mofetil
Zwerner, J., & Fiorentino, D. (2007). Mycophenolate mofetil. DERMATOLOGIC THERAPY, 20(4), 229–238.
-
Localized scleroderma and systemic sclerosis: Is there a connection?
Gupta, R. A., & Fiorentino, D. (2007). Localized scleroderma and systemic sclerosis: Is there a connection? BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 21(6), 1025–1036.
-
IL-10 ACTS ON THE ANTIGEN-PRESENTING CELL TO INHIBIT CYTOKINE PRODUCTION BY TH1 CELLS
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & OGARRA, A. (1991). IL-10 ACTS ON THE ANTIGEN-PRESENTING CELL TO INHIBIT CYTOKINE PRODUCTION BY TH1 CELLS. JOURNAL OF IMMUNOLOGY, 146(10), 3444–3451.
-
Dermatomyositis.
Krathen, M. S., Fiorentino, D., & Werth, V. P. (2008). Dermatomyositis. Current Directions in Autoimmunity, 10, 313–332.
-
ISOLATION AND EXPRESSION OF HUMAN CYTOKINE SYNTHESIS INHIBITORY FACTOR CDNA CLONES - HOMOLOGY TO EPSTEIN-BARR-VIRUS OPEN READING FRAME BCRFI
Vieira, P., DEWAALMALEFYT, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., … Moore, K. W. (1991). ISOLATION AND EXPRESSION OF HUMAN CYTOKINE SYNTHESIS INHIBITORY FACTOR CDNA CLONES - HOMOLOGY TO EPSTEIN-BARR-VIRUS OPEN READING FRAME BCRFI. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 88(4), 1172–1176.
-
Type I Interferon in the Induction or Exacerbation of Dermatomyositis What This Observation Tells Us About the Naturally Occurring Disease
Fiorentino, D. F. (2008). Type I Interferon in the Induction or Exacerbation of Dermatomyositis What This Observation Tells Us About the Naturally Occurring Disease. ARCHIVES OF DERMATOLOGY, 144(10), 1379–1382.
-
Imatinib in the Treatment of Nephrogenic Systemic Fibrosis
Chandran, S., Petersen, J., Jacobs, C., Forentino, D., Doeden, K., & Lafayette, R. A. (2009). Imatinib in the Treatment of Nephrogenic Systemic Fibrosis. AMERICAN JOURNAL OF KIDNEY DISEASES, 53(1), 129–132.
-
-
MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon A Randomized, Controlled Trial
Chung, L., Shapiro, L., Fiorentino, D., Baron, M., Shanahan, J., Sule, S., … Wigley, F. M. (2009). MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon A Randomized, Controlled Trial. ARTHRITIS AND RHEUMATISM, 60(3), 870–877.
-
IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & OGARRA, A. (1991). IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES. JOURNAL OF IMMUNOLOGY, 147(11), 3815–3822.
-
HETEROGENEITY OF MOUSE HELPER T-CELLS - EVIDENCE FROM BULK CULTURES AND LIMITING DILUTION CLONING FOR PRECURSORS OF TH1 AND TH2 CELLS
Street, N. E., SCHUMACHER, J. H., Fong, T. A. T., Bass, H., Fiorentino, D. F., LEVERAH, J. A., & Mosmann, T. R. (1990). HETEROGENEITY OF MOUSE HELPER T-CELLS - EVIDENCE FROM BULK CULTURES AND LIMITING DILUTION CLONING FOR PRECURSORS OF TH1 AND TH2 CELLS. JOURNAL OF IMMUNOLOGY, 144(5), 1629–1639.
-
-
-
-
A Pilot Study of Etanercept Treatment for Pemphigus Vulgaris
Fiorentino, D. F., Garcia, M. S., Rehmus, W., & Kimball, A. B. (2011). A Pilot Study of Etanercept Treatment for Pemphigus Vulgaris. ARCHIVES OF DERMATOLOGY, 147(1), 117–118.
-
Pathogenesis of dermatomyositis: role of cytokines and interferon.
Kao, L., Chung, L., & Fiorentino, D. F. (2011). Pathogenesis of dermatomyositis: role of cytokines and interferon. Current Rheumatology Reports, 13(3), 225–232.
-
ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR IL-4, IL-5, IL-6, AND A NEW TH2-SPECIFIC CYTOKINE (IL-10), CYTOKINE SYNTHESIS INHIBITORY FACTOR, BY USING A SOLID-PHASE RADIOIMMUNOADSORBENT ASSAY
Mosmann, T. R., SCHUMACHER, J. H., Fiorentino, D. F., LEVERAH, J., Moore, K. W., & Bond, M. W. (1990). ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR IL-4, IL-5, IL-6, AND A NEW TH2-SPECIFIC CYTOKINE (IL-10), CYTOKINE SYNTHESIS INHIBITORY FACTOR, BY USING A SOLID-PHASE RADIOIMMUNOADSORBENT ASSAY. JOURNAL OF IMMUNOLOGY, 145(9), 2938–2945.
-
-
HOMOLOGY OF CYTOKINE SYNTHESIS INHIBITORY FACTOR (IL-10) TO THE EPSTEIN-BARR-VIRUS GENE BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., TROUNSTINE, M. L., Khan, T. A., & Mosmann, T. R. (1990). HOMOLOGY OF CYTOKINE SYNTHESIS INHIBITORY FACTOR (IL-10) TO THE EPSTEIN-BARR-VIRUS GENE BCRFI. SCIENCE, 248(4960), 1230–1234.
-
EXPRESSION OF INTERLEUKIN-10 ACTIVITY BY EPSTEIN-BARR-VIRUS PROTEIN BCRF1
Hsu, D. H., Malefyt, R. D., Fiorentino, D. F., Dang, M. N., Vieira, P., Devries, J., … Moore, K. W. (1990). EXPRESSION OF INTERLEUKIN-10 ACTIVITY BY EPSTEIN-BARR-VIRUS PROTEIN BCRF1. SCIENCE, 250(4982), 830–832.
-
-
-
-
-
-
Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients
Higgs, B. W., Zhu, W., Richman, L., Fiorentino, D. F., Greenberg, S. A., Jallal, B., & Yao, Y. (2012). Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 15(1), 25–35.
-
A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies Report of 2 Cases and Review of the Literature
Chaisson, N. F., Paik, J., Orbai, A.-M., Casciola-Rosen, L., Fiorentino, D., Danoff, S., & Rosen, A. (2012). A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies Report of 2 Cases and Review of the Literature. MEDICINE, 91(4), 220–228.
-
Skin disease in dermatomyositis
Zaba, L. C., & Fiorentino, D. F. (2012). Skin disease in dermatomyositis. CURRENT OPINION IN RHEUMATOLOGY, 24(6), 597–601.
-
Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab
Sarin, K. Y., & Fiorentino, D. (2012). Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab. ARCHIVES OF DERMATOLOGY, 148(9), 990–992.
-
-
Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases
de Souza, A., Ali-Shaw, T., Reddy, S. M., Fiorentino, D., & Strober, B. E. (2013). Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases. BRITISH JOURNAL OF DERMATOLOGY, 168(1), 210–212.
-
Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey.
Linos, E., Fiorentino, D., Lingala, B., Krishnan, E., & Chung, L. (2013). Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey. Arthritis Research & Therapy, 15(1), R7-?
-
Localized cutaneous fibrosing disorders.
Yaqub, A., Chung, L., Rieger, K. E., & Fiorentino, D. F. (2013). Localized cutaneous fibrosing disorders. Rheumatic Diseases Clinics of North America, 39(2), 347–364.
-
2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989). 2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES. JOURNAL OF EXPERIMENTAL MEDICINE, 170(6), 2081–2095.
-
MOLECULAR ANALYSIS OF THE INTERACTION OF CALCINEURIN WITH DRUG-IMMUNOPHILIN COMPLEXES
Clipstone, N. A., Fiorentino, D. F., & Crabtree, G. R. (1994). MOLECULAR ANALYSIS OF THE INTERACTION OF CALCINEURIN WITH DRUG-IMMUNOPHILIN COMPLEXES. JOURNAL OF BIOLOGICAL CHEMISTRY, 269(42), 26431–26437.
-
-
TOR KINASE DOMAINS ARE REQUIRED FOR 2 DISTINCT FUNCTIONS, ONLY ONE OF WHICH IS INHIBITED BY RAPAMYCIN
Zheng, X. F., Fiorentino, D., Chen, J., Crabtree, G. R., & Schreiber, S. L. (1995). TOR KINASE DOMAINS ARE REQUIRED FOR 2 DISTINCT FUNCTIONS, ONLY ONE OF WHICH IS INHIBITED BY RAPAMYCIN. CELL, 82(1), 121–130.
-
The mechanism of action of cyclosporin A and FK506
Ho, S., Clipstone, N., Timmermann, L., Northrop, J., Graef, I., Fiorentino, D., … Crabtree, G. R. (1996). The mechanism of action of cyclosporin A and FK506. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 80(3), S40–S45.
-
-
Consensus Guidelines for the Management of Plaque Psoriasis
Hsu, S., Papp, K. A., Lebwohl, M. G., Bagel, J., Blauvelt, A., Duffin, K. C., … Bebo, B. F. (2012). Consensus Guidelines for the Management of Plaque Psoriasis. ARCHIVES OF DERMATOLOGY, 148(1), 95–102.
-
International consensus for a definition of disease flare in lupus
Ruperto, N., HANRAHAN, L. M., Alarcon, G. S., Belmont, H. M., Brey, R. L., Brunetta, P., … Merrill, J. T. (2011). International consensus for a definition of disease flare in lupus. LUPUS, 20(5), 453–462.
-
Comparison of the reliability & validity of outcome instruments for cutaneous dermatomyositis
Quain, R. D., Bangert, C. C., Costner, M., Connolly, M. K., Dugan, E., Tanikawa, A., … Werth, V. P. (2007). Comparison of the reliability & validity of outcome instruments for cutaneous dermatomyositis. Presented at the 68th Annual Meeting of the Society-for-Investigative-Dermatology, LOS ANGELES,CA: NATURE PUBLISHING GROUP.
-
-
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (2012). Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI. JOURNAL OF IMMUNOLOGY, 189(5), 1230–1234.
-
A Pilot Study of Abatacept for the Treatment of Patients with Diffuse Cutaneous Systemic Sclerosis.
Chakravarty, E. F., Fiorentino, D., Bennett, M., & Chung, L. (2011). A Pilot Study of Abatacept for the Treatment of Patients with Diffuse Cutaneous Systemic Sclerosis. ARTHRITIS AND RHEUMATISM, 63(10), S274–S275.
-
Molecular framework for response to imatinib mesylate in systemic sclerosis
Chung, L., Fiorentino, D. F., Benbarak, M. J., Adler, A. S., Mariano, M. M., Paniagua, R. T., … Robinson, W. H. (2008). Molecular framework for response to imatinib mesylate in systemic sclerosis. ARTHRITIS AND RHEUMATISM, 58(9), S819–S820.
-
Evaluation of an imatinib response gene signature in patients with systemic sclerosis
Chung, L., Ruiz, P., Wood, T., Shoor, S., Robinson, W., Whitfield, M., … Fiorentino, D. (2010). Evaluation of an imatinib response gene signature in patients with systemic sclerosis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(5), S62–S62.
-
Immune Responses to NXP-2 and TIF-g Are Associated with Distinct Clinical Phenotypes and Prognosis for Skin Disease in Dermatomyositis Patients.
Fiorentino, D., Chung, L., Zaba, L., Lingala, B., Rosen, A., & Casciola-Rosen, L. (2012). Immune Responses to NXP-2 and TIF-g Are Associated with Distinct Clinical Phenotypes and Prognosis for Skin Disease in Dermatomyositis Patients. ARTHRITIS AND RHEUMATISM, 64(10), S828–S828.
-
-
-
Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
Fleming, J. N., Nash, R. A., McLeod, D. O., Fiorentino, D. F., Shulman, H. M., Connolly, M. K., … Schwartz, S. M. (2008). Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype? PLOS ONE, 3(1).
-
HETEROGENEITY OF MOUSE HELPER T-CELLS AND CROSS-REGULATION OF TH1 AND TH2 CLONES
Mosmann, T. R., Street, N. E., Fiorentino, D. F., Bond, M. W., Fong, T. A. T., Schumacher, J., … Moore, K. W. (1989). HETEROGENEITY OF MOUSE HELPER T-CELLS AND CROSS-REGULATION OF TH1 AND TH2 CLONES. Presented at the 7TH INTERNATIONAL CONGRESS OF IMMUNOLOGY, BERLIN,FED REP GER: SPRINGER-VERLAG BERLIN.
-
-
-
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Higgs, B. W., Liu, Z., White, B., Zhu, W., White, W. I., Morehouse, C., … Yao, Y. (2011). Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. ANNALS OF THE RHEUMATIC DISEASES, 70(11), 2029–2036.
-
-
-
-
-
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?.
Fiorentino, D. F., Chung, L. S., Christopher-Stine, L., Zaba, L., Li, S., Mammen, A. L., … Casciola-Rosen, L. (2013). Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?. Arthritis and Rheumatism, 65(11), 2954–2962.
-
Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis: Higher Mortality Than Patients With Lupus and Rheumatoid Arthritis
Dave, A. J., Fiorentino, D., Lingala, B., Krishnan, E., & Chung, L. (2014). Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis: Higher Mortality Than Patients With Lupus and Rheumatoid Arthritis. ARTHRITIS CARE & RESEARCH, 66(2), 323–327.
-
-
The plasma cell signature in autoimmune disease.
Streicher, K., Morehouse, C. A., Groves, C. J., Rajan, B., Pilataxi, F., Lehmann, K. P., … Ranade, K. (2014). The plasma cell signature in autoimmune disease. Arthritis & Rheumatology (Hoboken, N.J.), 66(1), 173–184.
-
Localized cutaneous fibrosing disorders.
Yaqub, A., Chung, L., Rieger, K. E., & Fiorentino, D. F. (2013). Localized cutaneous fibrosing disorders. Rheumatic Diseases Clinics of North America, 39(2), 347–364.
-
-
-
-
-
-
-
-
-
PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjogren's syndrome
Fiorentino, D. F., Presby, M., Baer, A. N., Petri, M., Rieger, K. E., Soloski, M., … Casciola-Rosen, L. (2016). PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjogren's syndrome. ANNALS OF THE RHEUMATIC DISEASES, 75(6), 1145–1151.
-
-
-
-
Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study
Valenzuela, A., Baron, M., Herrick, A. L., Proudman, S., Stevens, W., Rodriguez-Reyna, T. S., … Chung, L. (2016). Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. SEMINARS IN ARTHRITIS AND RHEUMATISM, 46(3), 344–349.
-
Abstract 46: surgical treatment of systemic sclerosis: re-thinking the role and timing of peripheral sympathectomy.
Momeni, A., Sorice, S. C., Valenzuela, A., Fiorentino, D. F., Chung, L., & Chang, J. (2014). Abstract 46: surgical treatment of systemic sclerosis: re-thinking the role and timing of peripheral sympathectomy. Plastic and Reconstructive Surgery, 133(4), 1010-?
-
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
Strober, B. E., Bissonnette, R., Fiorentino, D., Kimball, A. B., Naldi, L., Shear, N. H., … Lebwohl, M. G. (2016). Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]). JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(5), 851-?
-
-
Ovoid Palatal Patch in Dermatomyositis: A Novel Finding Associated With Anti-TIF1? (p155) Antibodies.
Bernet, L. L., Lewis, M. A., Rieger, K. E., Casciola-Rosen, L., & Fiorentino, D. F. (2016). Ovoid Palatal Patch in Dermatomyositis: A Novel Finding Associated With Anti-TIF1? (p155) Antibodies. JAMA Dermatology, 152(9), 1049–51.
-
Pillars Article: IL-10 Inhibits Cytokine Production by Activated Macrophages. J. Immunol. 1991. 147: 3815-3822.
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O'Garra, A. (2016). Pillars Article: IL-10 Inhibits Cytokine Production by Activated Macrophages. J. Immunol. 1991. 147: 3815-3822. Journal of Immunology , 197(5), 1539–1546.
-
-
IL-10 ACTS ON THE ANTIGEN-PRESENTING CELL TO INHIBIT CYTOKINE PRODUCTION BY Th1 CELLS
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O'Garra, A. (2016). IL-10 ACTS ON THE ANTIGEN-PRESENTING CELL TO INHIBIT CYTOKINE PRODUCTION BY Th1 CELLS. JOURNAL OF IMMUNOLOGY, 197(5), 1531–1538.
-
Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea
Fett, N. M., Fiorentino, D., & Werth, V. P. (2016). Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea. DERMATOLOGIC CLINICS, 34(3), 243-?
-
-
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.
Lofgren, S., Hinchcliff, M., Carns, M., Wood, T., Aren, K., Arroyo, E., … Khatri, P. (2016). Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. JCI Insight, 1(21).
-
IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O'Garra, A. (2016). IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES. JOURNAL OF IMMUNOLOGY, 197(5), 1539–46.
-
-
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., … Vencovsky, J. (2017). 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. ARTHRITIS & RHEUMATOLOGY, 69(5), 898–910.
-
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., … Vencovsky, J. (2017). 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. ANNALS OF THE RHEUMATIC DISEASES, 76(5).
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Feb 2018
Good.
SHC Patient, Dec 2017
to be relieved of pain is incredible.
SHC Patient, Dec 2017
Dr. Fiorentino is a fantastic doctor. I have great confidence in his judgment and diagnostic skills. He explains information in an easy to understand manner. He is very warm and kind in his interaction with me.
SHC Patient, Dec 2017
Dr. Fiorentino is exceptional.
SHC Patient, Nov 2017
I am grateful for dr Fiorentino and dr welliis to be my docs and to be following me through my healing process with medical expertise, compassion and practical advice. they are clear communicators. thank you.
SHC Patient, Oct 2017
This is very good.
SHC Patient, Sep 2017
I would highly recommend Dr. Florentino.
SHC Patient, Sep 2017
Once the specialist came into the room, they were very attentive and collaborative. I felt they gave me a lot of time and weren't rushed, they were extremely patient and helpful in providing guidance and next steps with a plan to address my diagnosis.
SHC Patient, Sep 2017
I have always and continue to be impressed by all of my interaction with the Dermatology group...from beginning to end.
SHC Patient, Aug 2017
I never feel rushed by my dr. he spends plenty of time with me.
SHC Patient, Aug 2017
Dr. Fiorentino is awesome, trustworthy, professional and thorough - as always.
SHC Patient, May 2017
Caring, helpful, walked out feeling happy.
SHC Patient, Apr 2017
Dr. Fiorentino is the very best. I am lucky to have him as a care provider...
SHC Patient, Apr 2017
Would be more helpful for a paper showing exactly on the body each prescription (name) should be under. There was some confusion without a visual. Want to emphasize the provider is the very best and I highly recommend him.
SHC Patient, Feb 2017
Very good experience.
SHC Patient, Dec 2016
Good.
SHC Patient, Nov 2016
The dr. was so good - I will be driving over an hour to see him - rather than stick with my current dr. - who is only a few miles from work.
SHC Patient, Nov 2016
Dr. Fiorentino spent ample time with me. He described very well my specific issues and treatment options.
SHC Patient, Oct 2016
I am getting the best care. Very pleased
SHC Patient, Oct 2016
Dr. Fiorentino is outstanding!
SHC Patient, Jul 2016
Good.
SHC Patient, Jul 2016
Absolutely LOVE Dr. Florentino. Am physician myself so am very discriminating.
SHC Patient, Jul 2016
Dr. Fiorentino is excellent
SHC Patient, May 2016
nothing but the best care to their ability have I received
SHC Patient, May 2016
I love Drs Fiorentino and Chiou!!
SHC Patient, Apr 2016
Satisfied with care and providers learning more about the rare auto immune disease I have.
SHC Patient, Mar 2016
Dr. Fiorentino is outstanding. I NEVER feel rushed. He takes the amount of time necessary to answer all of my questions and treats the dr./patient relationship as a partnership. Excellent provider.
SHC Patient, Mar 2016
Excellent in every area of care & concern!
SHC Patient, Mar 2016
Dr. Fiorentino is the best!!
SHC Patient, Feb 2016
Dr. Gamba and Dr Fiorentino are excellent, caring, and knowledgeable doctors who explain everything very well and encourage feedback and questions. They are top professionals.
SHC Patient, Feb 2016
Both Dr. Fiorentino and Dr. Christina Gamba (the resident) provided excellent care.
SHC Patient, Feb 2016
The treatment initiated by Dr. Fiorentino has really changed my life and allowed me to resume the activities I could otherwise not do -
SHC Patient, Jan 2016
Felt very comfortable with Dr. Lucina Chung and Dr. David Fiorentino.
SHC Patient, Jan 2016
She was the best there that I have had.
SHC Patient, Dec 2015
Dr. David Fidentino is terrific!
SHC Patient, Dec 2015
Good
SHC Patient, Nov 2015
Dr. Fiorentino came highly recommended. The results I have had give me the highest confidence in Dr. Fiorentino. Without a doubt I would highly recommend him to others.
SHC Patient, Nov 2015
Always the best
SHC Patient, Oct 2015
Dr. Fiorentino and Dr. Chiou are simply the best! They treat me with a lot of respect and I feel that they genuinely care about me and my condition!
SHC Patient, Jul 2015
Good.
SHC Patient, Jul 2015
I was able to get a diagnose for my condition that the doctors in my hometown couldn't figure out. I will forever be grateful to Dr. Fiorentino and Dr. Chiou!
SHC Patient, Jul 2015
Love Dr. Fiorentino, wish he was my internist.
SHC Patient, Jul 2015
Dr. Fiorentino is the best and so is his staff. they are kind, courteous and really care for the well being of their patients. They are always amazing and if it wasn't for Dr. Fiorentino I wouldn't be able to walk with my psoriasis and his knowledge. he's the best!!!
SHC Patient, Jul 2015
I have had a foot problem for 2 years with no relief from other physicians. This has been the first time I've actually felt confidence in a positive outcome. Good staff from start to finish.
SHC Patient, Apr 2015
An "all excellent" experience~Thank you for hiring qualified people for this clinic :)
SHC Patient, Apr 2015
I'd like to express my thanks to Dr Fiorentino and Dr Bernet for their diagnostic insight pointing the cause of my Dermititus to hematology problem. I'm currently in chemo therapy treatment for CMML-1 leukemia.
SHC Patient, Mar 2015
my provider is a very caring giver with concerns to my condition which is severe in its aspects
SHC Patient, Mar 2015
Dr. Florentino is simply the best!
SHC Patient, Mar 2015
Dr. Fiorentino is a caring, brilliant, personable, and knowledgeable dermatologist.
SHC Patient, Mar 2015
Dr. Fiorentino is superb! Absolutely amazing, caring doctor top expert in psoriasis.
SHC Patient, Jan 2015
I have every confidence in Doctor Firoentino and highly recommend him. He cleared a condition others had been unable to.
SHC Patient, Mar 2014
Dr. Fiorentino has served me well and is working hard to help me with complicated skin issues. I appreciate him very much.
SHC Patient, Feb 2018
Good.
SHC Patient, Dec 2017
to be relieved of pain is incredible.
SHC Patient, Dec 2017
Dr. Fiorentino is a fantastic doctor. I have great confidence in his judgment and diagnostic skills. He explains information in an easy to understand manner. He is very warm and kind in his interaction with me.
SHC Patient, Dec 2017
Dr. Fiorentino is exceptional.
SHC Patient, Nov 2017
I am grateful for dr Fiorentino and dr welliis to be my docs and to be following me through my healing process with medical expertise, compassion and practical advice. they are clear communicators. thank you.
SHC Patient, Oct 2017
This is very good.
SHC Patient, Sep 2017
I would highly recommend Dr. Florentino.
SHC Patient, Sep 2017
Once the specialist came into the room, they were very attentive and collaborative. I felt they gave me a lot of time and weren't rushed, they were extremely patient and helpful in providing guidance and next steps with a plan to address my diagnosis.
SHC Patient, Sep 2017
I have always and continue to be impressed by all of my interaction with the Dermatology group...from beginning to end.
SHC Patient, Aug 2017
I never feel rushed by my dr. he spends plenty of time with me.
SHC Patient, Aug 2017
Dr. Fiorentino is awesome, trustworthy, professional and thorough - as always.
SHC Patient, May 2017
Caring, helpful, walked out feeling happy.
View All 52 Patient Comments »